{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:36:20Z","timestamp":1784892980512,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Unresectable, isolated lymph node recurrence after radiotherapy is rare but a candidate for re-irradiation. However, severe toxicity is anticipated. Therefore, this study aimed to explore the efficacy and toxicity of re-irradiation in isolated lymph node recurrence of head and neck lesions. We analyzed 46 patients who received re-irradiation for lymph node recurrence without local progression. The primary tumor sites included the oral cavity in 17 patients, the hypopharynx in 12, the oropharynx in seven, the larynx in three, the nasopharynx in two, and other sites. During a median follow-up time of 10\u00a0months, the median survival time was 10.6\u00a0months, and the 1-year overall survival rate was 45.5%. The 1-year local control and progression-free survival rates were 49.8% and 39.3%, respectively. According to univariate analysis, age (\u2265\u200965\u00a0years), the interval between treatment (\u2265\u200912\u00a0months), rN category (rN1), and gross tumor volume (GTV\u2009&lt;\u200925\u00a0cm<jats:sup>3<\/jats:sup>) were predisposing factors for better survival. In the multivariate analysis, the rN category and interval were identified as statistically significant predictors. Late toxicity grade\u2009\u2265\u20093 occurred in four patients (8.6%). These were all Grade 5 carotid blowout syndrome, which associated with tumor invasion of the carotid artery and\/ or high doses administration for the carotid artery. Small-volume rN1 tumor that recur after a longer interval is a feasible candidate for re-irradiation. However, strict patient selection and meticulous care for the carotid are required.<\/jats:p>","DOI":"10.1038\/s41598-024-53438-w","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T08:02:46Z","timestamp":1707292966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Re-irradiation for isolated neck recurrence in head and neck tumor: impact of rN category"],"prefix":"10.1038","volume":"14","author":[{"given":"Hideya","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Aibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoong-jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Ogita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"53438_CR1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/annonc\/mdh308","volume":"15","author":"B Brockstein","year":"2004","unstructured":"Brockstein, B. et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience. Ann. Oncol. 15, 1179\u20131186 (2004).","journal-title":"Ann. Oncol."},{"key":"53438_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier, J. et al. European organization for research and treatment of cancer trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 350, 1945\u20131952 (2004).","journal-title":"N. Engl. J. Med."},{"key":"53438_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","volume":"359","author":"JB Vermorken","year":"2008","unstructured":"Vermorken, J. B. et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N. Engl. J. Med. 359, 1116\u20131127 (2008).","journal-title":"N. Engl. J. Med."},{"key":"53438_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.radonc.2009.08.038","volume":"93","author":"M Lambrecht","year":"2009","unstructured":"Lambrecht, M., Dirix, P., Van den Bogaert, W. & Nuyts, S. Incidence of isolated regional recurrence after definitive (chemo-) radiotherapy for head and neck squamous cell carcinoma. Radiother. Oncol. 93, 498\u2013502 (2009).","journal-title":"Radiother. Oncol."},{"key":"53438_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2006.08.017","volume":"81","author":"S Chopra","year":"2006","unstructured":"Chopra, S. et al. Re-irradiation in the management of isolated neck recurrences: current status and recommendations. Radiother. Oncol. 81, 1\u20138 (2006).","journal-title":"Radiother. Oncol."},{"key":"53438_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hed.20580","volume":"29","author":"SL Liauw","year":"2007","unstructured":"Liauw, S. L. et al. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck. Head Neck 29, 715\u2013719 (2007).","journal-title":"Head Neck"},{"key":"53438_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/(SICI)1097-0347(199910)21:7<591::AID-HED1>3.0.CO;2-Y","volume":"21","author":"SR Mabanta","year":"1999","unstructured":"Mabanta, S. R., Mendenhall, W. M., Stringer, S. P. & Cassisi, N. J. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 21, 591\u2013594 (1999).","journal-title":"Head Neck"},{"key":"53438_CR8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ijrobp.2004.12.062","volume":"62","author":"S Temam","year":"2005","unstructured":"Temam, S. et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 62, 1078\u20131083 (2005).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR9","first-page":"162","volume":"35","author":"L Putten","year":"2015","unstructured":"Putten, L. et al. Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: Outcome and review. Acta Otorhinolaryngol Ital 35, 162\u2013172 (2015).","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"53438_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1200\/JCO.1992.10.2.257","volume":"10","author":"C Jacobs","year":"1992","unstructured":"Jacobs, C. et al. A phase-III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous-cell carcinoma of the head and neck. J. Clin Oncol 10, 257\u2013263 (1992).","journal-title":"J. Clin Oncol"},{"key":"53438_CR11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/1097-0142(19831101)52:9<1563::AID-CNCR2820520904>3.0.CO;2-R","volume":"51","author":"C Jacobs","year":"1983","unstructured":"Jacobs, C., Meyers, F., Hendrickson, C., Kohler, M. & Carter, S. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California oncology group study. Cancer 51, 1563\u20131569 (1983).","journal-title":"Cancer"},{"key":"53438_CR12","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3390\/cancers13102371","volume":"13","author":"F Ionna","year":"2021","unstructured":"Ionna, F. et al. Recurrent\/metastatic squamous cell carcinoma of the head and neck: A big and intriguing challenge which may be resolved by integrated treatments combining locoregional and systemic therapies. Cancers 13, 2371 (2021).","journal-title":"Cancers"},{"key":"53438_CR13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","volume":"7","author":"TY Seiwert","year":"2016","unstructured":"Seiwert, T. Y. et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): An open-label, multicentre, phase 1b trial. Lancet Oncol. 7, 956\u2013965 (2016).","journal-title":"Lancet Oncol."},{"key":"53438_CR14","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1200\/JCO.2008.20.0691","volume":"27","author":"T Tanvetyanon","year":"2009","unstructured":"Tanvetyanon, T. et al. Prognostic factors for survival after salvage reirradiation of head and neck cancer. J. Clin. Oncol. 27, 1983\u20131991 (2009).","journal-title":"J. Clin. Oncol."},{"key":"53438_CR15","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1200\/JCO.2007.15.0102","volume":"26","author":"F Janot","year":"2008","unstructured":"Janot, F. et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J. Clin. Oncol. 26, 5518\u20135523 (2008).","journal-title":"J. Clin. Oncol."},{"key":"53438_CR16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0360-3016(01)01745-X","volume":"51","author":"SA Spencer","year":"2001","unstructured":"Spencer, S. A. et al. RTOG 96\u201310: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 51, 1299\u20131304 (2001).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.radonc.2011.06.025","volume":"100","author":"J Tortochaux","year":"2011","unstructured":"Tortochaux, J. et al. Randomized phase III trial (GORTEC 98\u201303) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. Radiother. Oncol. 100, 70\u201375 (2011).","journal-title":"Radiother. Oncol."},{"key":"53438_CR18","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1200\/JCO.1998.16.11.3556","volume":"16","author":"R De Crevoisier","year":"1998","unstructured":"De Crevoisier, R. et al. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J. Clin. Oncol. 16, 3556\u20133562 (1998).","journal-title":"J. Clin. Oncol."},{"key":"53438_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ijrobp.2017.11.036","volume":"100","author":"JJ Caudell","year":"2018","unstructured":"Caudell, J. J. et al. Multi-Institution Reirradiation (MIRI). Collaborative volume, dose, and fractionation considerations for IMRT-based reirradiation in head and neck cancer: A multi-institution analysis. Int. J. Radiat. Oncol. Biol. Phys. 100, 606\u2013617 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.04.021","volume":"73","author":"EP Sulman","year":"2009","unstructured":"Sulman, E. P. et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int. J. Radiat. Oncol. Biol. Phys. 73, 399\u2013409 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ijrobp.2017.04.017","volume":"100","author":"JA Vargo","year":"2018","unstructured":"Vargo, J. A. et al. A Multi-institutional Comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 100, 595\u2013605 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/jrr\/rrw004","volume":"57","author":"H Yamazaki","year":"2016","unstructured":"Yamazaki, H. et al. Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer. J Radiat Res 57, 288\u2013293 (2016).","journal-title":"J Radiat Res"},{"key":"53438_CR23","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijrobp.2017.06.012","volume":"100","author":"MC Ward","year":"2018","unstructured":"Ward, M. C. et al. Multi-Institution Reirradiation (MIRI) Collaborative. Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT Era: A multi-institution cohort study by the MIRI collaborative. Int. J. Radiat. Oncol. Biol. Phys. 100, 586\u2013594 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.radonc.2010.10.025","volume":"98","author":"N Tselis","year":"2011","unstructured":"Tselis, N. et al. Hypofractionated accelerated CT-guided interstitial 192Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother. Oncol. 98, 57\u201362 (2011).","journal-title":"Radiother. Oncol."},{"key":"53438_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.radonc.2013.08.012","volume":"109","author":"EF Lartigau","year":"2013","unstructured":"Lartigau, E. F. et al. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol 109, 281\u2013285 (2013).","journal-title":"Radiother Oncol"},{"key":"53438_CR26","first-page":"8","volume":"2019","author":"D Kobayashi","year":"1911","unstructured":"Kobayashi, D. et al. Efficacy and feasibility of salvage re-irradiation with CyberKnife for in-field neck lymph node recurrence: a retrospective study. J. Clin. Med. 2019, 8 (1911).","journal-title":"J. Clin. Med."},{"key":"53438_CR27","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/hed.24872","volume":"39","author":"C Pollard 3rd","year":"2017","unstructured":"Pollard, C. 3rd. et al. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck 39, 2079\u20132087 (2017).","journal-title":"Head Neck"},{"key":"53438_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/hed.23542","volume":"37","author":"P Strojan","year":"2015","unstructured":"Strojan, P. et al. Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate. Head Neck 37, 134\u2013150 (2015).","journal-title":"Head Neck"},{"key":"53438_CR29","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/hed.26264","volume":"42","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: Meta-analysis and systematic review. Head Neck 42, 2473\u20132485 (2020).","journal-title":"Head Neck"},{"key":"53438_CR30","doi-asserted-by":"publisher","first-page":"104757","DOI":"10.1016\/j.oraloncology.2020.104757","volume":"107","author":"J Lee","year":"2020","unstructured":"Lee, J., Kim, W. C., Yoon, W. S., Koom, W. S. & Rim, C. H. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review. Oral. Oncol. 107, 104757 (2020).","journal-title":"Oral. Oncol."},{"key":"53438_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.radonc.2013.05.005","volume":"107","author":"H Yamazaki","year":"2013","unstructured":"Yamazaki, H. et al. Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: A multi-institutional study. Radiother. Oncol. 107, 305\u2013309 (2013).","journal-title":"Radiother. Oncol."},{"key":"53438_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."},{"key":"53438_CR33","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1038\/s41598-023-29459-2","volume":"13","author":"H Yamazaki","year":"2023","unstructured":"Yamazaki, H. et al. Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional study. Sci. Rep. 13, 3062 (2023).","journal-title":"Sci. Rep."},{"key":"53438_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1748-717X-5-51","volume":"5","author":"K Kawaguchi","year":"2010","unstructured":"Kawaguchi, K. et al. Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat. Oncol. 5, 51 (2010).","journal-title":"Radiat. Oncol."},{"key":"53438_CR35","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1002\/hed.26820","volume":"43","author":"K Diao","year":"2021","unstructured":"Diao, K. et al. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study. Head Neck 43, 3331\u20133344 (2021).","journal-title":"Head Neck"},{"key":"53438_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0360-3016(99)00164-9","volume":"45","author":"K Yoshida","year":"1999","unstructured":"Yoshida, K. et al. Radiotherapy of early tongue cancer in patients less than 40 years old. Int. J. Radiat. Oncol. Biol. Phys. 45, 367\u2013371 (1999).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2015.02.021","volume":"115","author":"H Yamazaki","year":"2015","unstructured":"Yamazaki, H. et al. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis. Radiother. Oncol. 115, 67\u201371 (2015).","journal-title":"Radiother. Oncol."},{"key":"53438_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijrobp.2020.12.037","volume":"110","author":"J Grimm","year":"2021","unstructured":"Grimm, J. et al. Initial data pooling for radiation dose-volume tolerance for carotid artery blowout and other bleeding events in hypofractionated Head and Neck retreatments. Int. J. Radiat. Oncol. Biol. Phys. 110, 147\u2013159 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR39","doi-asserted-by":"publisher","first-page":"103088","DOI":"10.1016\/j.critrevonc.2020.103088","volume":"155","author":"D Alterio","year":"2020","unstructured":"Alterio, D. et al. Carotid blowout syndrome after reirradiation for head and neck malignancies: A comprehensive systematic review for a pragmatic multidisciplinary approach. Crit. Rev. Oncol. Hematol. 155, 103088 (2020).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"53438_CR40","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.3390\/cancers13133173","volume":"13","author":"A Embring","year":"2021","unstructured":"Embring, A. et al. Re-irradiation for head and neck cancer: Cumulative dose to organs at risk and late side effects. Cancers 13, 3173 (2021).","journal-title":"Cancers"},{"key":"53438_CR41","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/1748-717X-8-242","volume":"8","author":"G Yazici","year":"2013","unstructured":"Yazici, G. et al. A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers. Radiat. Oncol. 8, 242 (2013).","journal-title":"Radiat. Oncol."},{"key":"53438_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijrobp.2010.04.027","volume":"81","author":"M Cengiz","year":"2011","unstructured":"Cengiz, M. et al. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. Int. J. Radiat. Oncol Biol. Phys. 81, 104\u2013109 (2011).","journal-title":"Int. J. Radiat. Oncol Biol. Phys."},{"key":"53438_CR43","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ijrobp.2010.08.029","volume":"82","author":"MW McDonald","year":"2012","unstructured":"McDonald, M. W., Moore, M. G. & Johnstone, P. A. Risk of carotid blowout after reirradiation of the head and neck: A systematic review. Int. J. Radiat. Oncol. Biol. Phys. 82, 1083\u20131089 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"53438_CR44","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1684\/bdc.2013.1829","volume":"100","author":"J Thariat","year":"2013","unstructured":"Thariat, J. et al. \u00c9volution des concepts dans les cancers des voies a\u00e9rodigestives sup\u00e9rieures, sous l\u2019\u00e9gide de l\u2019Intergroupe ORL (GORTEC, GETTEC, GERCOR) [Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC]. Bull Cancer 100, 983\u2013997 (2013) (in French).","journal-title":"Bull Cancer"},{"key":"53438_CR45","first-page":"83","volume":"6","author":"DC Ling","year":"2019","unstructured":"Ling, D. C. et al. Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer. J. Radiosurg. SBRT 6, 83\u201389 (2019).","journal-title":"J. Radiosurg. SBRT"},{"key":"53438_CR46","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1002\/mp.13121","volume":"45","author":"P Mavroidis","year":"2018","unstructured":"Mavroidis, P. et al. Fitting NTCP models to SBRT dose and carotid blowout syndrome data. Med. Phys. 45, 4754\u20134762 (2018).","journal-title":"Med. Phys."},{"key":"53438_CR47","doi-asserted-by":"publisher","first-page":"907","DOI":"10.6004\/jnccn.2020.7594","volume":"18","author":"HN Vasudevan","year":"2020","unstructured":"Vasudevan, H. N. & Yom, S. S. Combining systemic therapy with radiation: head and neck cancer treatments in an era of targeted agents and immunotherapy. J. Natl. Compr. Canc. Netw. 18, 907\u2013913 (2020).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"53438_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","volume":"7","author":"EEW Cohen","year":"2019","unstructured":"Cohen, E. E. W. et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J. Immunother. Cancer. 7, 184 (2019).","journal-title":"J. Immunother. Cancer."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53438-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53438-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53438-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T08:04:52Z","timestamp":1707293092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53438-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53438"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-53438-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3107"}}